Literature DB >> 12741904

Clear cell carcinoid tumor of the gallbladder. A case without von Hippel-Lindau disease.

Eiichi Konishi1, Yasuaki Nakashima, Thomas C Smyrk, Seiji Masuda.   

Abstract

A golden yellow polyp was detected in the gallbladder of a 64-year-old man who presented with epigastric pain. The lesion was composed of clear polygonal cells arranged in a trabecular and glandular pattern. The tumor invaded through the wall into the perimuscular subserosal layer. Immunohistochemical stains showed that neoplastic cells were positive for chromogranin A, synaptophysin, somatostatin, gastrin, and pancreatic polypeptide and negative for glucagon, serotonin, insulin, S100 protein, and inhibin. This tumor resembles the recently described clear cell endocrine tumors of the gallbladder and pancreas that are associated with von Hippel-Lindau disease. Our patient, however, had neither personal nor family history indicative of von Hippel-Lindau disease. Furthermore, published accounts of clear cell endocrine tumors in von Hippel-Lindau disease describe immunoreactivity for inhibin; the current case was negative for the disease. There may be a subtype of clear cell carcinoid tumor not associated with von Hippel-Lindau disease, which is characterized by its lack of immunoreactivity against inhibin.

Entities:  

Mesh:

Year:  2003        PMID: 12741904     DOI: 10.5858/2003-127-745-CCCTOT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Clear cell carcinoid of the appendix: an uncommon variant of lipid-rich neuroendocrine tumor with a broad differential diagnosis.

Authors:  Giulio Rossi; Nazarena Nannini; Federica Bertolini; Maria Cecilia Mengoli; Rita Fano; Alberto Cavazza
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Neuroendocrine tumors of the gallbladder: a case report and review of the literature.

Authors:  Silvia Mezi; Vincenzo Petrozza; Orazio Schillaci; Valentina La Torre; Barbara Cimadon; Martina Leopizzi; Errico Orsi; Filippo La Torre
Journal:  J Med Case Rep       Date:  2011-07-29

Review 3.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

4.  Clear cell neuroendocrine tumor G1 of the gallbladder without von Hippel-Lindau disease.

Authors:  Mitsuaki Ishida; Hisanori Shiomi; Shigeyuki Naka; Tohru Tani; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-09-06       Impact factor: 2.967

5.  Lipid-rich ("clear cell") neuroendocrine tumors of the pancreas in MEN I patients.

Authors:  Eve Fryer; Stefano Serra; Runjan Chetty
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

6.  Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.

Authors:  Hasan Gucer; Eva Szentgyorgyi; Shereen Ezzat; Sylvia L Asa; Ozgur Mete
Journal:  Virchows Arch       Date:  2013-08-04       Impact factor: 4.064

Review 7.  Clear cell carcinoid tumor of the distal common bile duct.

Authors:  Takeshi Todoroki; Takaaki Sano; Shuji Yamada; Nobutsune Hirahara; Naotaka Toda; Katsuhiko Tsukada; Ryuji Motojima; Teiji Motojima
Journal:  World J Surg Oncol       Date:  2007-01-17       Impact factor: 2.754

8.  Neuroendocrine tumor of the gallbladder.

Authors:  Ahmed Monier; Nehal Saloum; Wojciech Szmigielski; Amal Alrashid; Sarbar M E Napaki
Journal:  Pol J Radiol       Date:  2015-01-05

9.  Renal Cell Carcinoma Metastasis to the Gallbladder Detected by FDG-PET/CT.

Authors:  Aung Zaw Win
Journal:  J Clin Med Res       Date:  2014-09-09

10.  A 0.8-cm clear cell neuroendocrine tumor G1 of the gallbladder with lymph node metastasis: a case report.

Authors:  Yuki Hirose; Jun Sakata; Kazuhiko Endo; Masato Takahashi; Reijiro Saito; Hiroshi Imano; Tomoki Kido; Kei Yoshino; Toshiki Sasaki; Toshifumi Wakai
Journal:  World J Surg Oncol       Date:  2018-07-23       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.